Skip to Main Content

Paper Details

Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma.
Clin Cancer Res
12
2021
Author NameAffiliation
Osama MohamadUniversity of Texas Southwestern Medical Center
Osama MohamadUniversity of California San Francisco
Chul AhnHarold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center
Chul AhnQuantitative Biomedical Research Center, University of Texas Southwestern Medical Center
Brandi L CantarelUniversity of Texas Southwestern Medical Center
Lindsay G CowellUniversity of Texas Southwestern Medical Center
Lindsay G CowellUniversity of Texas Southwestern Medical Center
Tao WangQuantitative Biomedical Research Center, University of Texas Southwestern Medical Center
  • 1 - 8

Datasets